2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3326
  



  

  
Submitter : 
  

  
Mr. Norman Stephen
  

  
Date & Time: 
  

  
12/15/2006 08:12:07
  



  

  
Organization : 
  

  
Mr. Norman Stephen
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 I urge you to issue guidelines which will restrict pharmaceutical companies to use only stem cell lines established from non-fetal sources in the manufacture of vaccines.